Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
Androgen Replacement to Improve Patient-Important Outcomes in Men With Opioid-Induced Hypogonadism
Brigham and Women's Hospital
150 participants
Jan 10, 2022
INTERVENTIONAL
Conditions
Summary
The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception, pain tolerance, sexual function, fatigue, and quality of life when compared with placebo in men with chronic spinal pain treated with opioids who have opioid-induced hypogonadism (low testosterone).
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intramuscular administration at a dose of 750 mg at baseline, weeks 4, and week 14.
Intramuscular administration of placebo at baseline, weeks 4, and week 14.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04798469